The latest report by IMARC Group, titled “Endoluminal Suturing Devices Market Report by Application (Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Surgery, and Others), End Use (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032“, The global endoluminal suturing devices market size reached US$ 72.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 187.0 Million by 2032, exhibiting a growth rate (CAGR) of 11.2% during 2024-2032.
Factors Affecting the Growth of the Endoluminal Suturing Devices Industry:
- Technological Advancements:
Technological innovations in suturing devices, including miniaturization, enhanced maneuverability, and the use of advanced materials, are significant contributors to market growth. These improvements have made suturing devices more effective and more adaptable to a variety of surgical environments. Additionally, miniaturization allows for smaller incisions, which is essential in reducing recovery times and minimizes scarring. Moreover, improved maneuverability enhances the precision with which surgeons can operate, which is essential in complex procedures where every millimeter matters. Moreover, several advancements in materials have led to stronger, more durable sutures that are less likely to cause reactions and can improve the healing process. Collectively, these technological advances enhance patient outcomes by reducing complications during and after surgery, thereby driving greater demand for advanced suturing devices in surgical practices worldwide.
- Increasing Prevalence of Chronic Diseases:
The rising prevalence of chronic diseases such as obesity, gastrointestinal disorders, and cardiovascular diseases is driving the need for minimally invasive surgical interventions. Additionally, endoluminal suturing devices are increasingly used in these procedures due to their ability to facilitate complex surgeries with minimal physical intrusion. These devices play an essential role in procedures such as gastric bypasses, which are common in treating obesity, or in repairing blood vessels in cardiovascular operations. Along with this, the capability of endoluminal suturing devices to deliver precise surgical outcomes with reduced patient trauma is essential in managing chronic conditions effectively. As these diseases become more common due to aging populations and lifestyle factors, the demand for efficient, minimally invasive surgical tools like endoluminal suturing devices continues to grow, highlighting their importance in modern medical practice across the globe.
- Rising Demand for Minimally Invasive Procedures:
The global shift toward minimally invasive procedures reflects patients’ preferences for surgeries that offer faster recovery times, less post-operative pain, and fewer complications. Additionally, endoluminal suturing devices are providing an essential tool for performing such surgeries. These devices allow surgeons to perform complex suturing tasks through small incisions or natural body openings, which significantly reduces the trauma associated with open surgeries. This approach shortens hospital stays and reduces the risk of infections and other complications, leading to better overall patient experiences and outcomes. As more patients and healthcare providers recognize the benefits of minimally invasive techniques, the adoption of endoluminal suturing devices is expected to increase, further propelling their market growth and innovation.
Competitive Landscape with Key Player:
- Apollo Endosurgery Inc.
- ErgoSuture
- Ovesco Endoscopy AG
- Usgi Medical Inc.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/endoluminal-suturing-devices-market/requestsample
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Application:
- Bariatric Surgery
- Gastrointestinal Surgery
- Gastroesophageal Surgery
- Others
Gastrointestinal surgery represents the largest segment due to the prevalence of conditions like obesity and GERD requiring minimally invasive procedures across the globe.
Breakup by End Use:
- Hospitals
- Ambulatory Surgical Centers
- Others
Hospitals account for the largest market share due to their advanced facilities and increasing patient throughput for surgical procedures.
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America’s dominance in the endoluminal suturing devices market is attributed to higher healthcare expenditure, technological advancements, and widespread adoption of minimally invasive (MI) surgeries across the region.
Global Endoluminal Suturing Devices Market Trends:
At present, as demand grows for minimally invasive (MI) surgeries, endoluminal suturing devices play a crucial role. They enable procedures that reduce recovery times, minimize trauma, and lower healthcare costs. Additionally, several conditions like obesity and gastrointestinal disorders are influencing the market growth. Moreover, endoluminal suturing devices are widely employed in the treatment of these conditions, driving market growth. Besides this, several regulatory approvals and standards continue to evolve, impacting market entry strategies and product development timelines for manufacturers. Furthermore, with the increasing pressure on healthcare costs, there is a growing emphasis on demonstrating the cost-effectiveness of these devices to secure reimbursement and adoption across the globe.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
